Interleukin‐33‐nuclear factor‐κB‐CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells

Esophageal cancer is currently one of the most fatal cancers. However, there is no effective treatment. Increasing evidence suggests that interleukin (IL)‐33 has a significant role in tumor progression and metastasis. Currently, the underlying cellular and molecular mechanism of IL‐33 in promoting e...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Ying, Lian, Jingyao, Wang, Tian, Luo, Chenghan, Yuan, Yiqiang, Qin, Guohui, Zhang, Bin, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060484/
https://www.ncbi.nlm.nih.gov/pubmed/31883400
http://dx.doi.org/10.1111/cas.14293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060484/
https://www.ncbi.nlm.nih.gov/pubmed/31883400
http://dx.doi.org/10.1111/cas.14293

Ejemplares similares